课题基金 / 基金详情

Core A Verkman Screening Core

Core A Verkman Screening Core
核心 A Verkman 筛选核心
批准号:
8564917
负责人:
ALAN S VERKMAN
金额:
$16.07万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-06-01 至 2015-05-31

项目摘要

项目成果

ALAN S VERKMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY (See instructions): The high-throughput screening core will continue to carry out screening of small-molecule libraries against defined targets or phenotypes. Resources of the core at present include more than 250,000 drug-like compounds and smaller collections of purified natural compounds and approved/investigational drugs, and automated instrumentation for high-throughput screening utilizing optical (fluorescence, absorbance, luminescence) assays. Functions of the core include compound storage and handling, assay design and validation, assay execution, and data analysis. Initial optimization of validated 'hits' (compounds with activity against defined targets or phenotypes) is done by screening of commercially purchased compound analogs. Further 'hit-to-lead' development is done in individual projects in consultation with the core. The core has been utilized extensively during the current project with successful identification and characterization of novel modulators of ion transporters and infection. The core will be heavily utilized by 28 ongoing and new CF related projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Urea transport inhibitors as a new class of diuretics
Urea transport inhibitors as a new class of diuretics
Urea transport inhibitors as a new class of diuretics
Application of Novel Optical Methods to Cell Dynamics
海外基金